Our team brings together a perfect balance of experience, expertise, and youthful energy in our mission to revolutionize cancer treatment. In addition, we benefit from the support of several KOLs and high-level advisors.
Laboratory - PepKon has its own laboratory at Oncodesign François Hyafil research center (Villebon-sur-Yvette, Paris region). This asset enables the company to synthesize its own peptides and conduct laboratory studies.
Incubation and offices - PepKon is supported by three selective incubators : Agoranov, Neighborhood (Voisin Consulting Life Sciences) and Prunay Impact.
FILO - PepKon is supported for its preclinical and clinical development by FILO, the national Cooperative Group of research in the field of Chronic Lymphocytic Leukemia.